Home|
Intro|
Faculty|
Program|
Contact|
Lev5


Thursday, March 29, 2007
Chairpersons:
Werner Poewe, MD, Innsbruck, Austria
Anthony Schapira, MD, DSc, FRCP, FMedSci, London, UK



8:30 Introduction

8:40 A Brief History of Dopamine
Oleh Hornykiewicz, MD, Vienna, Austria

9:05 Pharmacology of Dopamine Receptor Agonists
Peter Jenner, MD, PhD, DSc, London, UK

9:30 Dopamine in Sensory-Motor Control
Alfredo Berardelli, MD, Rome, Italy

9:55 Panel Discussion

10:20 Break

10:50 Dopamine in Sleep and RLS
David B. Rye, MD, PhD, Atlanta, GA, USA

11:15 Dopamine and the Regulation of Mood and Behavior
Yves Agid, MD, PhD, Paris, France

11:40 Depressive Symptoms in PD and RLS —
Treatment Options
Matthias Lemke, MD, Bonn, Germany

12:05 The Challenge of Studying Depression in PD
Paolo Barone, MD, PhD, Naples, Italy

12:30 Research Program in RLS
Luigi Ferini-Strambi, MD, Milan, Italy

12:45 Panel Discussion

13:15 Lunch Break

14:30 Video Sessions (Parallel Sessions)
Moderators: A. Antonini, K. R. Chaudhuri, S. Fahn,
B. Högl, R. Katzenschlager, J. Montplaisir, W. Oertel,
M.M. Partinen, A. Schrag, F. Stocchi, J.W. Winkelman


15:30 Break

15:50 Controversies: Pro and Con Discussions

■ Dyskinesia Prevention in PD Is Possible and Meaningful
YES: Werner Poewe, MD, Innsbruck, Austria
NO: Eduardo Tolosa, MD, FRCP, Barcelona, Spain

■ Early Treatment Benefits PD Patients
YES: Anthony H. V. Schapira, MD, DSc, FRCP, FMedSci, London, UK
NO: Christopher G. Goetz, MD, Chicago, IL, USA

■ Treatment Initiation for PD Should Be With MAO-B Inhibitors
YES: Stanley Fahn, MD, New York, NY, USA
NO: W. Oertel, MD, Marburg, Germany

■ RLS Is Underdiagnosed and Undertreated
YES: Kapil D. Sethi, MD, FRCP, Augusta, GA, USA
NO: Birgit Högl, MD, Innsbruck, Austria

17:50 Close of Meeting



Friday, March 30, 2007
Chairpersons:
Paolo Barone, MD, PhD, Naples, Italy
Wayne Hening, MD, PhD, New Brunswick, NJ, USA



8:30 Introduction

8:40 Societal and Personal Costs of RLS
Richard P. Allen, PhD, Baltimore, MD, USA

9:05 Current Evidence on Treatment Interventions for RLS
Wayne Hening, MD, PhD, New Brunswick, NJ, USA

9:30 Long-Term Management of RLS
Diego Garcia-Borreguero, MD, Madrid, Spain

9:55 Panel Discussion

10:25 Break

10:55 Pathophysiology of Dyskinesias in PD
Warren Olanow, MD, New York, NY, USA

11:20 Continuous Dopaminergic Stimulation in PD —
Is it the Only Answer to the Motor Complications of Levodopa?
Eduardo Tolosa, MD, FRCP, Barcelona, Spain

11:45 Early Diagnosis and the Benefits of Early Treatment
Anthony H. V. Schapira, MD, DSc, FRCP, FMedSci, London, UK

12:10 Novel Therapeutic Approaches in PD and RLS —
Waiting for a Breakthrough?
Werner Poewe, MD, Innsbruck, Austria

12:35 Panel Discussion

13:05 Lunch

14:15 Local Workshops


Vienna, Austria
29–30 March 2007




  Home|Intro|Faculty|Program|Contact|Lev5    


Copyright © 2008-2012 LMS Group, Paris
Website creation by netactif